Description
Tesamorelin is a modified peptide analogue of endogenous GHRH designed for increased stability and resistance to enzymatic degradation. It is commonly used in research settings to study pulsatile growth hormone signaling and downstream endocrine pathways.
The molecule includes structural modifications (e.g., trans-3-hexenoyl group) that differentiate it from native GHRH and influence its pharmacokinetic profile in experimental models.
Research applications (investigational)
Tesamorelin has been investigated in preclinical and experimental settings for its involvement in:
Growth hormone (GH) secretion dynamics
Hypothalamic–pituitary axis signaling
Insulin-like growth factor 1 (IGF-1) pathway modulation
Metabolic regulation in controlled research models
Adipose tissue and lipid metabolism studies
Endocrine feedback mechanisms
These areas reflect ongoing scientific interest in regulated hormone signaling rather than established applications.
Product characteristics
Purity: ≥ 98% (HPLC)
Appearance: white lyophilized powder
Molecular formula: C221H366N72O67S
Molecular weight: 5135.78
CAS No: 218949-48-5
Storage: store lyophilized powder at -20°C, protect from light and moisture. Reconstituted solution should be kept at 2–8°C and used within a short period.
Why choose our Tesamorelin
High-purity peptide verified by HPLC
Identity confirmed via MS (ESI)
Batch-specific Certificate of Analysis available
Produced under controlled manufacturing conditions
Lyophilized for stability and long-term storage
NOTE: This is for educational reference only and does not constitute medical advice.
Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.
Reviews
There are no reviews yet.